Cited by CrossRef (1)
- Megan Stringer, Irushi Abeysekera, Karl J. Dria, Randall J. Roper, Charles R. Goodlett. Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model. Pharmacology Biochemistry and Behavior 2015;138:70
